Inventor
ARASAPPAN ASHOK
US48 patents
⚠️ This page may combine multiple inventors who share the name “ARASAPPAN ASHOK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
21 patentsUS6911428B2Jun 28, 2005
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP124 citations98
US6838475B2Jan 4, 2005
Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP121 citations97
US6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US7205330B2Apr 17, 2007
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP54 citations95
US6914122B2Jul 5, 2005
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
SCHERING CORP89 citations95
US6846802B2Jan 25, 2005
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
SCHERING CORP124 citations95
US7592316B2Sep 22, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP34 citations93
US7399749B2Jul 15, 2008
Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP21 citations93
US7485625B2Feb 3, 2009
Inhibitors of hepatitis C virus NS3/NS4a serine protease
SCHERING CORP33 citations92
US7342041B2Mar 11, 2008
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7192957B2Mar 20, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7186747B2Mar 6, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP47 citations92
US7173057B2Feb 6, 2007
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
SCHERING CORP44 citations92
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US7425576B2Sep 16, 2008
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP20 citations91
US7816326B2Oct 19, 2010
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP9 citations84
US7423058B2Sep 9, 2008
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP15 citations83
US7619094B2Nov 17, 2009
Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
SCHERING CORP5 citations62
US7718691B2May 18, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations51
US7595299B2Sep 29, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP0 citations51
US7759499B2Jul 20, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations49
MERCK SHARP & DOHME
11 patentsUS11377438B2Jul 5, 2022
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors
MERCK SHARP & DOHME6 citations83
US9290517B2Mar 22, 2016
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
MERCK SHARP & DOHME8 citations82
US11028092B2Jun 8, 2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
MERCK SHARP & DOHME2 citations73
US10934294B2Mar 2, 2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
MERCK SHARP & DOHME2 citations72
US9868733B2Jan 16, 2018
Azabenzimidazole tetrahydrofuran derivatives
MERCK SHARP & DOHME4 citations72
US9556193B2Jan 31, 2017
Benzimidazole hexahydrofuro[3,2-b]furan derivatives
MERCK SHARP & DOHME4 citations71
US10806724B2Oct 20, 2020
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME0 citations51
US10335399B2Jul 2, 2019
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME0 citations51
US10072003B2Sep 11, 2018
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME1 citations51
US11802122B2Oct 31, 2023
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
MERCK SHARP & DOHME0 citations50
US9650375B2May 16, 2017
Indole derivatives useful as anti-diabetic agents
MERCK SHARP & DOHME0 citations40
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
MERCK SHARP & DOHME LLC
3 patentsUS12195445B2Jan 14, 2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations60
US12247031B2Mar 11, 2025
Cyclobutyl pyrazolopyrimidine PDE9 inhibitors
MERCK SHARP & DOHME LLC0 citations51
US12516046B2Jan 6, 2026
2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations46
GIRIJAVALLABHAN VINAY
2 patentsUS9061041B2Jun 23, 2015
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY49 citations93
US9156872B2Oct 13, 2015
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY45 citations92